February 16, 2022
A Novel, High-Throughput Platform to Characterize Novel IBD Therapeutics
RepliGut Planar Model provides a model to study TNF-a inflammation in the gut and conduct high-throughput screening of IBD therapeutics.
December 23, 2020
How Does Altis Biosystems Envision the Future of the Pharma/Biopharma Industry?
Altis Biosystems offers human intestinal models that accurately translate results from preclinical experiments to late-stage clinical trials.